Multiple labial melanotic macules occurring after topical application of calcineurin inhibitors

Vivian Y. Shi, Jayne S Joo, Victoria R. Sharon

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Topical calcineurin inhibitors are widely used to treat inflammatory dermatoses for their steroid-sparing advantage. Herein, we report a patient with chronic lip dermatitis who developed multiple labial melanotic macules after application of tacrolimus 0.1% ointment and pimecrolimus 1% cream. Prior and current reports raise concerns for potential development of pigmented lesions associated with topical calcineurin inhibitor use. These reports highlight the need for careful risk-benefit assessment when prescribing topical calcineurin inhibitors for inflammatory dermatoses, especially when used on sun-exposed sites.

Original languageEnglish (US)
JournalDermatology Online Journal
Volume20
Issue number8
StatePublished - 2014

Fingerprint

Lip
Skin Diseases
Tacrolimus
Solar System
Dermatitis
Ointments
Steroids
Calcineurin Inhibitors

ASJC Scopus subject areas

  • Dermatology

Cite this

Multiple labial melanotic macules occurring after topical application of calcineurin inhibitors. / Shi, Vivian Y.; Joo, Jayne S; Sharon, Victoria R.

In: Dermatology Online Journal, Vol. 20, No. 8, 2014.

Research output: Contribution to journalArticle

@article{2517439164854ec7bb2749c1556b3eec,
title = "Multiple labial melanotic macules occurring after topical application of calcineurin inhibitors",
abstract = "Topical calcineurin inhibitors are widely used to treat inflammatory dermatoses for their steroid-sparing advantage. Herein, we report a patient with chronic lip dermatitis who developed multiple labial melanotic macules after application of tacrolimus 0.1{\%} ointment and pimecrolimus 1{\%} cream. Prior and current reports raise concerns for potential development of pigmented lesions associated with topical calcineurin inhibitor use. These reports highlight the need for careful risk-benefit assessment when prescribing topical calcineurin inhibitors for inflammatory dermatoses, especially when used on sun-exposed sites.",
author = "Shi, {Vivian Y.} and Joo, {Jayne S} and Sharon, {Victoria R.}",
year = "2014",
language = "English (US)",
volume = "20",
journal = "Dermatology Online Journal",
issn = "1087-2108",
publisher = "Department of Dermatology UC Davis",
number = "8",

}

TY - JOUR

T1 - Multiple labial melanotic macules occurring after topical application of calcineurin inhibitors

AU - Shi, Vivian Y.

AU - Joo, Jayne S

AU - Sharon, Victoria R.

PY - 2014

Y1 - 2014

N2 - Topical calcineurin inhibitors are widely used to treat inflammatory dermatoses for their steroid-sparing advantage. Herein, we report a patient with chronic lip dermatitis who developed multiple labial melanotic macules after application of tacrolimus 0.1% ointment and pimecrolimus 1% cream. Prior and current reports raise concerns for potential development of pigmented lesions associated with topical calcineurin inhibitor use. These reports highlight the need for careful risk-benefit assessment when prescribing topical calcineurin inhibitors for inflammatory dermatoses, especially when used on sun-exposed sites.

AB - Topical calcineurin inhibitors are widely used to treat inflammatory dermatoses for their steroid-sparing advantage. Herein, we report a patient with chronic lip dermatitis who developed multiple labial melanotic macules after application of tacrolimus 0.1% ointment and pimecrolimus 1% cream. Prior and current reports raise concerns for potential development of pigmented lesions associated with topical calcineurin inhibitor use. These reports highlight the need for careful risk-benefit assessment when prescribing topical calcineurin inhibitors for inflammatory dermatoses, especially when used on sun-exposed sites.

UR - http://www.scopus.com/inward/record.url?scp=84906256929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906256929&partnerID=8YFLogxK

M3 - Article

C2 - 25148283

AN - SCOPUS:84906256929

VL - 20

JO - Dermatology Online Journal

JF - Dermatology Online Journal

SN - 1087-2108

IS - 8

ER -